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Background: Effective diabetes prevention strategies that can be implemented in daily practice, without huge
amounts of money and a lot of personnel are needed. The Dutch Diabetes Federation developed a protocol for
coaching people with impaired fasting glucose (IFG; according to WHO criteria: 6.1 to 6.9 mmol/l) to a sustainable
healthy lifestyle change: ‘the road map towards diabetes prevention’ (abbreviated: Road Map: RM). This protocol is
applied within a primary health care setting by a general practitioner and a practice nurse. The feasibility and
(cost-) effectiveness of care provided according to the RM protocol will be evaluated.
Methods/Design: A cluster randomised clinical trial is performed, with randomisation at the level of the general
practices. Both opportunistic screening and active case finding took place among clients with high risk factors for
diabetes. After IFG is diagnosed, motivated people in the intervention practices receive 3–4 consultations by the
practice nurse within one year. During these consultations they are coached to increase the level of physical activity
and healthy dietary habits. If necessary, participants are referred to a dietician, physiotherapist, lifestyle programs
and/or local sports activities. The control group receives care as usual. The primary outcome measure in this study
is change in Body Mass Index (BMI). Secondary outcome measures are waist circumference, physical activity, total
and saturated fat intake, systolic blood pressure, blood glucose, total cholesterol, HDL cholesterol, triglycerides and
behaviour determinants like risk perception, perceived knowledge and motivation. Based on a sample size
calculation 120 people in each group are needed. Measurements are performed at baseline, and after one (post-
intervention) and two years follow up. Anthropometrics and biochemical parameters are assessed in the practices
and physical activity, food intake and their determinants by a validated questionnaire. The cost-effectiveness is esti-
mated by using the Chronic Disease Model (CDM). Feasibility will be tested by interviews among health care profes-
sionals.
Discussion: The results of the study will provide valuable information for both health care professionals and policy
makers. If this study shows the RM to be both effective and cost-effective the protocol can be implemented on a
large scale.
Trial registration: ISRCTN41209683. Ethical approval number: NL31342.075.10.
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Diabetes is an increasing problem which affects approxi-
mately 371 million people worldwide [1]. In 2011 the
estimated prevalence in the Netherlands was 834.100
people with diabetes, of which 90% with type 2 diabetes
mellitus (T2DM), with an annual estimate of newly
discovered cases of 71,000 in that year [2]. This number
translates into approximately 5% of the total Dutch
population and is expected to rise to 1,300,000 and
1,600,000 in 2025 [3]. Many of these people are not
aware of their risk of diabetes, but already have impaired
fasting glucose (IFG; according to WHO criteria: 6.1 to
6.9 mmol/l). It is estimated, that some 750.000 people in
the Netherlands between 30 and 70 years of age have
either IFG or impaired glucose tolerance (IGT) [4].
People with IFG not only have a high risk of developing
T2DM on short term, but also have an increased cardio-
vascular risk [5]. Without changes in lifestyle and proper
support, about 9% of people with IFG will develop
T2DM within three years [6].
When IFG is diagnosed, follow-up often is not well or-
ganized. The Diabetes Mellitus type 2 guideline of the
Dutch College of General Practitioners 2006 advices a
regular check in people known with IFG for develop-
ment of T2DM and to treat their cardiovascular risk
factors [7]. However, these people are not monitored
systematically: most of the times a simple life style ad-
vice is given, combined with the advice to have fasting
blood glucose measured at regular intervals. Health care
providers indicate that there is a need for support in
coaching people with IFG in a more systematic and in-
tensive way. They also indicate that they do not know
how to handle this group [8].
Lifestyle interventions which focus on both physical
activity and diet can be effective for people diagnosed
with IFG, with a relative risk reduction of 43% seven
years after the start of the intervention [9,10]. Another
study shows a similar risk reduction which sustained
even 20 years after the start [11,12] Also Dutch projects
show that it is possible to stimulate people to change
their lifestyle [13-15]. For example, the SLIM study
shows an improvement of glucose tolerance, which sus-
tained after three years [16]. While the studies men-
tioned above show that a health gain can be achieved by
people at risk for diabetes, another Dutch study on redu-
cing risk by lifestyle change did not show the expected
effects and proved to be not cost-effective [17]. Still it is
concluded that combined lifestyle interventions are
likely to have great potential as a strategy to prevent dia-
betes. Actually, these most successful interventions were
obtained using many personnel and intensive supervi-
sion while the current practice requests less expensive,
simple interventions which can be easily carried out in
daily practice.For above mentioned reason and in order to meet the
needs of both people at high risk to develop T2DM and
health care professionals, the Dutch Diabetes Federation
(NDF) developed a protocol for coaching persons with
an increased risk of diabetes in general practice called
‘the road map towards diabetes prevention’ (abbreviated:
Road Map: RM). It aims to delay or even prevent the
development of T2DM and associated cardiovascular
risk factors. The protocol is developed according to the
framework of the Diabetes Mellitus type 2 Guideline of
the Dutch College of General Practitioners [7]. To in-
clude people in the protocol, people at risk for diabetes
were stimulated to fill out the Diabetes Risk Test (DRT).
The DRT consists of ten questions covering risk factors
for diabetes, and provides a score for the probability of
developing diabetes within five years [9,18]. This paper de-
scribes the design of a RCT into the feasibility and (cost-)
effectiveness of care provided according to the RM.
Methods
Study design
A clustered randomized controlled trial is carried out to
study the feasibility and (cost-)effectiveness of the RM.
Randomization takes place at the level of the general
practices. The subjects in the intervention group are
treated according to the RM. Persons in the control
group receive care as usual, including one consultation
each year, according to the T2DM guideline of the
Dutch College of General Practitioners [7]. A baseline
measurement takes place just after the diagnosis of IFG
and just before the start of the intervention. Outcome
measurements are performed one year after the diagno-
sis (t1, 1-year follow-up) and two years after the diagno-
sis (t2, 2-year follow up) (Figure 1).
Recruitment of general practices
Recruitment of general practices takes place in the
North-eastern region of the Netherlands. Only practices
which employ a practice nurse are included. Both, the
general practitioner and the practice nurse are respon-
sible for the recruitment and inclusion of participants.
Recruitment of participants
Potential participants are selected by opportunistic
screening and active case finding. Selection criteria for
both are the absence of the diagnose diabetes and age
(≥45). For opportunistic screening additional selection
criteria are weight (BMI ≥ 25) and the presence of car-
diovascular risk factors. Opportunistic screening takes
place during consultations with the general practitioner
and/or practice nurse. Active screening is based on the
patient files in the general practices. Selected individuals
receive a mailing in which they are asked to do the DRT
at home or the DRT is filled out during the consultation.
Study population




- general practices N=25
- patients N=120
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- patients N=120
Baseline measurement Baseline measurement
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Figure 1 Study design.
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glucose measure has to be taken.Study population
All subjects diagnosed with IFG and motivated to
change their lifestyle are included in the study. Exclusion
criteria are previous education about IFG or diabetes,
emotional, psychological or intellectual problems that
are likely to limit the ability of the individual to comply
with the protocol, malignant diseases or other diseases
or conditions associated with a poor prognosis.Training
The practice nurse carries out the intervention with sup-
port of the general practitioner, if necessary. Besides car-
rying out the RM, the practice nurses are responsible for
the data collection. Prior to the start of the study, all
practice nurses of the intervention group are trained to
support them in applying the protocol. Additionally they
are trained in techniques of motivational interviewing.Randomisation
To avoid contamination of care as usual by the interven-
tion, the randomisation takes place at the level of the gen-
eral practices. General practices within the same health
center are allocated to the same study group. A compu-
terised random number generator is used to allocate the
practices to the intervention or the control group.
Intervention
The RM protocol is based on the ‘stages of change’
model [19]. In this model change is considered as a
process directed towards progress through a series of
stages (precontemplation, contemplation, preparation,
action and maintenance). The education and counselling
of an individual persons’ needs depend on the stage he
or she is in. People in the precontemplation and con-
templation stage require information about the advances
of a healthy lifestyle. People in the preparation stage are
already aware of the advantages and disadvantages of a
healthy lifestyle and require counselling and guidance to
improve their ability to change their lifestyle. In the ac-
tion stage, people do require tips and strategies for
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people may need additional guidance and feedback to
stimulate them in maintaining their changed behaviour
and to prevent relapse.
The first section of the protocol focuses on case find-
ing and testing (Figure 2). The general practitioner is re-
sponsible for assessing subjects’ individual risk to
develop T2DM. When someone is diagnosed with IFG,
the second section of the RM is applied (Figure 3). This
section of the protocol focuses on coaching the individ-
ual person to a healthy lifestyle. The practice nurse triesNormalTreatment of risk factors 
according the Diabetes 
Mellitus type 2 Guideline of 
the Dutch College of 
General Practitioners. 







guidelines of the Dutch
College of General 
Practitioners
Low risk
DRT Score ≤ 6
Somewhat higher risk




Figure 2 Case finding and testing (first section of the RM protocol).to get insight into the motivational situation of the par-
ticipant. Based on this insight, three to four extra con-
sultations spread over a one year period are carried out.
During these consultations the practice nurse gives ad-
vice and teaches concrete and applicable skills in order
to increase the level of physical activity and healthy diet-
ary habits. If necessary, participants are referred to a
dietician, physiotherapist, lifestyle programs and/or local
sports activities. The practice nurse applies motivational
interviewing techniques to determine someone’s motiv-
ational situation and to help a person to change his orDetermine 
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Figure 3 Counselling schedule (second section of the RM protocol).
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[19,20]. After one year participants receive care as usual.
After the initial development of the RM protocol it
has been piloted on practical feasibility in different small
scale pilot studies. The results of these pilots were used
to improve the protocol.Care as usual
Care as usual for those with IFG means a yearly check
on diabetes-related symptoms and blood glucose levels
according to the T2DM guideline of the Dutch College
of General Practitioners [7].Outcomes
The primary outcome measure in this study is change
in Body Mass Index (BMI). Secondary outcome mea-
surements are waist circumference, total and saturated
fat intake, physical activity, systolic blood pressure,
blood glucose, total cholesterol, triglycerides and
the behaviour determinants risk perception, perceived
knowledge, motivation, attitude, self efficacy and social
norm.Measurements
Medical records The practice nurse measures body
weight, blood pressure and waist circumference. Fasting
plasma glucose levels, HbA1c, and serum lipids are de-
termined in regional laboratories. Information on family
history of diabetes, history of elevated blood glucose,
ethnicity, other cardiovascular risk factors and comor-
bidity are recorded by the practice nurse. Furthermore,
the practice nurse is responsible for collecting and
reporting this data at three moments in time: just after
the diagnosis (t0) and during the yearly follow-up con-
sultations (t1 and t2).
Questionnaires
All participants are asked to complete a questionnaire at
three different time points. The questionnaire is handed
over by the practice nurse to the participants right after
the diagnosis (t0) and after the yearly follow-up consul-
tations (t1 and t2). Participants send the questionnaire
directly to the researchers. The questionnaire at t0 com-
prises general background information on demographic
characteristics (including sex, age, ethnicity, education,
household composition and occupational situation). The
questionnaires at t0, t1 and t2 comprise general health
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alcohol consumption), dietary habits (including total and
saturated fat intake) [21] and physical activity (including
minutes of light, moderate and intense physical activity
per week) [22]. Furthermore, promoting and inhibiting
factors for compliance are asked (including appreciation
of care regarding to their high risk on diabetes, self-
efficacy regarding lifestyle change, attitude towards life-
style change and social norm on healthy living).Process evaluation
A process evaluation is carried out to gather information
about the care given in the intervention and control
group. This evaluation consists of registration forms,
questions in the questionnaire of the intervention group
at t1 and t2, and face-to-face interviews with the practice
nurses responsible for the study. Time spent on the
intervention is recorded on registration forms. In the
questionnaires participants in both groups are asked
about their experiences with the offered care and refer-
rals. In each participating general practice a face-to-face
interview with the practice nurse responsible for the
study takes place. During these interviews information is
gathered about the inclusion of participants, the imple-
mentation of the care, the education and motivation of
the practice nurses, the number of referrals, experienced
motivation and treatment possibilities of the partici-
pants. In the intervention group practice nurse are asked
about the perceived effect of the RM and advice for fur-
ther implementation of the RM.Sample size calculation
The sample size calculation is estimated based on BMI
with the objective to detect a decrease in BMI of 0.5 in
the intervention group. In the SLIM study, the standard
error of the mean in change in BMI was 0.2 kg/m2 and
the standard deviation 1.37 [16]. The SLIM study has a
comparable population to this study, so it is assumed
that the standard error and standard deviations are also
comparable. To adjust for clusters, an intra-cluster cor-
relation of 0.011 is used [23]. Furthermore, a power of
80% and a two-sided alpha of 0.05 is used. Based on
these assumptions, 120 people in each group are needed.Analysis
Effects Multivariate variance and regression analysis are
carried out to determine differences in effect on the pri-
mary and secondary outcome measures. All analyses are
adjusted for baseline measurements and possible differ-
ences between both groups at baseline. To adjust for
clustering, multilevel analyses are performed.Cost-effectiveness
Costs of the care according to the RM are related to
determined effects on BMI and physical activity. The
cost-effectiveness is estimated by using the Chronic
Disease Model (CDM) developed by the Dutch National
Institute for Public Health and the Environment (RIVM)
[24-26]. The CDM is a Markov type multi-transition
model. The model computes life time health effects,
effect on health care costs and costs per quality-adjusted
life year (QALY) resulting from the minimum and max-
imum estimated intervention effect. A cost-effectiveness
ratio of less than 20.000 euro per QALY gained is con-
sidered cost-effective [27,28].
Discussion
The aim of the study is to investigate whether the use of
the RM adds value (for money) compared to the usual
care for people with IFG. The results of the study are
used as input in the discussion about integrating lifestyle
interventions like the RM in the Dutch health care. The
study is carried out in a real life situation: in the daily care
by general practices. This means that if effects are found,
it is likely these effects of the intervention will sustain
when the protocol is implemented on a wider scale.
Thus, the results of the study provide valuable information
for both health care professionals and policy makers. When
this study proves the RM to be both effective and cost-
effective, it will be recommended for all healthcare profes-
sionals to integrate protocolled coaching for people with an
increased risk of diabetes into daily care in general practice.
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